Cargando…

The prevalence and importance of frailty in cardiac resynchronization therapy patients

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Public grant(s) – EU funding. Main funding source(s): Nemzeti Kardiovaszkuláris Laboratórium RRF-2.3.1-21-2022-00003. BACKGROUND: Frailty, characterized by loss of homeostatic reserves and increased vulnerability to physiological decompensation, res...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuthi, L, Behon, A, Merkel, E, Schwertner, W R, Masszi, R, Veres, B, Kovacs, A, Osztheimer, I, Zima, E, Molnar, L, Geller, L, Kosztin, A, Merkely, B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207441/
http://dx.doi.org/10.1093/europace/euad122.457
_version_ 1785046454314729472
author Kuthi, L
Behon, A
Merkel, E
Schwertner, W R
Masszi, R
Veres, B
Kovacs, A
Osztheimer, I
Zima, E
Molnar, L
Geller, L
Kosztin, A
Merkely, B
author_facet Kuthi, L
Behon, A
Merkel, E
Schwertner, W R
Masszi, R
Veres, B
Kovacs, A
Osztheimer, I
Zima, E
Molnar, L
Geller, L
Kosztin, A
Merkely, B
author_sort Kuthi, L
collection PubMed
description FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Public grant(s) – EU funding. Main funding source(s): Nemzeti Kardiovaszkuláris Laboratórium RRF-2.3.1-21-2022-00003. BACKGROUND: Frailty, characterized by loss of homeostatic reserves and increased vulnerability to physiological decompensation, results from an aggregation of insults across multiple organ systems. Frailty can be quantified by counting the number of ‘health deficits’ across a range of domains. AIMS: We assessed the frequency of, and outcomes related to frailty in patients with heart failure and reduced ejection fraction who previously underwent cardiac resynchronization therapy (CRT) implantation. METHODS: We used a cumulative deficits approach to construct a 30-item frailty index (FI) and applied it to identify frail patients enrolled in our CRT registry. The 30 items were derived from medical history, other patient characteristics and laboratory results, covering a range of body systems. In keeping with previous studies, patients with FI ≤0.210 were classified as non-frail and those with higher scores were divided into two categories using score increments of 0.100. Our primary endpoint was all-cause mortality. RESULTS: Among 1004 included patients, 75 (7%) were considered Non-frail, while 271 (27%) and 658 (66%) participants were categorized as Frail in groups 1- and 2. Patients in Frail group 2 were older, had a less favorable renal function, and generally had more comorbidities (i.e. atrial fibrillation, hypertension, ischemic cardiovascular disease) than patients categorized in the Non-frail or Frail group 1. During the median follow-up time of 4.4 (2.3-6.9) years, 17 (22%) patients in the Non-frail group, 103 (38%) in Frail group 1, and 479 (73%) in the Frail group 2 reached the primary endpoint. Non-frail patient group showed the most beneficial survival with a 70% (HR 0.31; 95% CI: 0.23-0.41; p<0.001) lower all-cause mortality risk compared to Frail group 2. Adjusting for relevant covariates, NYHA class, creatinine, and TAPSE were identified as independent predictors for all-cause mortality. CONCLUSION: Based on our results, CRT candidates are exceedingly vulnerable with a high prevalence of frailty. The calculated frailty index was associated with the primary outcome of death from any cause. FI proved to be prevalent in individual risk stratification and can predict the outcome. [Figure: see text] [Figure: see text]
format Online
Article
Text
id pubmed-10207441
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-102074412023-05-25 The prevalence and importance of frailty in cardiac resynchronization therapy patients Kuthi, L Behon, A Merkel, E Schwertner, W R Masszi, R Veres, B Kovacs, A Osztheimer, I Zima, E Molnar, L Geller, L Kosztin, A Merkely, B Europace 14.3 - Cardiac Resynchronisation Therapy (CRT) FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Public grant(s) – EU funding. Main funding source(s): Nemzeti Kardiovaszkuláris Laboratórium RRF-2.3.1-21-2022-00003. BACKGROUND: Frailty, characterized by loss of homeostatic reserves and increased vulnerability to physiological decompensation, results from an aggregation of insults across multiple organ systems. Frailty can be quantified by counting the number of ‘health deficits’ across a range of domains. AIMS: We assessed the frequency of, and outcomes related to frailty in patients with heart failure and reduced ejection fraction who previously underwent cardiac resynchronization therapy (CRT) implantation. METHODS: We used a cumulative deficits approach to construct a 30-item frailty index (FI) and applied it to identify frail patients enrolled in our CRT registry. The 30 items were derived from medical history, other patient characteristics and laboratory results, covering a range of body systems. In keeping with previous studies, patients with FI ≤0.210 were classified as non-frail and those with higher scores were divided into two categories using score increments of 0.100. Our primary endpoint was all-cause mortality. RESULTS: Among 1004 included patients, 75 (7%) were considered Non-frail, while 271 (27%) and 658 (66%) participants were categorized as Frail in groups 1- and 2. Patients in Frail group 2 were older, had a less favorable renal function, and generally had more comorbidities (i.e. atrial fibrillation, hypertension, ischemic cardiovascular disease) than patients categorized in the Non-frail or Frail group 1. During the median follow-up time of 4.4 (2.3-6.9) years, 17 (22%) patients in the Non-frail group, 103 (38%) in Frail group 1, and 479 (73%) in the Frail group 2 reached the primary endpoint. Non-frail patient group showed the most beneficial survival with a 70% (HR 0.31; 95% CI: 0.23-0.41; p<0.001) lower all-cause mortality risk compared to Frail group 2. Adjusting for relevant covariates, NYHA class, creatinine, and TAPSE were identified as independent predictors for all-cause mortality. CONCLUSION: Based on our results, CRT candidates are exceedingly vulnerable with a high prevalence of frailty. The calculated frailty index was associated with the primary outcome of death from any cause. FI proved to be prevalent in individual risk stratification and can predict the outcome. [Figure: see text] [Figure: see text] Oxford University Press 2023-05-24 /pmc/articles/PMC10207441/ http://dx.doi.org/10.1093/europace/euad122.457 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle 14.3 - Cardiac Resynchronisation Therapy (CRT)
Kuthi, L
Behon, A
Merkel, E
Schwertner, W R
Masszi, R
Veres, B
Kovacs, A
Osztheimer, I
Zima, E
Molnar, L
Geller, L
Kosztin, A
Merkely, B
The prevalence and importance of frailty in cardiac resynchronization therapy patients
title The prevalence and importance of frailty in cardiac resynchronization therapy patients
title_full The prevalence and importance of frailty in cardiac resynchronization therapy patients
title_fullStr The prevalence and importance of frailty in cardiac resynchronization therapy patients
title_full_unstemmed The prevalence and importance of frailty in cardiac resynchronization therapy patients
title_short The prevalence and importance of frailty in cardiac resynchronization therapy patients
title_sort prevalence and importance of frailty in cardiac resynchronization therapy patients
topic 14.3 - Cardiac Resynchronisation Therapy (CRT)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207441/
http://dx.doi.org/10.1093/europace/euad122.457
work_keys_str_mv AT kuthil theprevalenceandimportanceoffrailtyincardiacresynchronizationtherapypatients
AT behona theprevalenceandimportanceoffrailtyincardiacresynchronizationtherapypatients
AT merkele theprevalenceandimportanceoffrailtyincardiacresynchronizationtherapypatients
AT schwertnerwr theprevalenceandimportanceoffrailtyincardiacresynchronizationtherapypatients
AT masszir theprevalenceandimportanceoffrailtyincardiacresynchronizationtherapypatients
AT veresb theprevalenceandimportanceoffrailtyincardiacresynchronizationtherapypatients
AT kovacsa theprevalenceandimportanceoffrailtyincardiacresynchronizationtherapypatients
AT osztheimeri theprevalenceandimportanceoffrailtyincardiacresynchronizationtherapypatients
AT zimae theprevalenceandimportanceoffrailtyincardiacresynchronizationtherapypatients
AT molnarl theprevalenceandimportanceoffrailtyincardiacresynchronizationtherapypatients
AT gellerl theprevalenceandimportanceoffrailtyincardiacresynchronizationtherapypatients
AT kosztina theprevalenceandimportanceoffrailtyincardiacresynchronizationtherapypatients
AT merkelyb theprevalenceandimportanceoffrailtyincardiacresynchronizationtherapypatients
AT kuthil prevalenceandimportanceoffrailtyincardiacresynchronizationtherapypatients
AT behona prevalenceandimportanceoffrailtyincardiacresynchronizationtherapypatients
AT merkele prevalenceandimportanceoffrailtyincardiacresynchronizationtherapypatients
AT schwertnerwr prevalenceandimportanceoffrailtyincardiacresynchronizationtherapypatients
AT masszir prevalenceandimportanceoffrailtyincardiacresynchronizationtherapypatients
AT veresb prevalenceandimportanceoffrailtyincardiacresynchronizationtherapypatients
AT kovacsa prevalenceandimportanceoffrailtyincardiacresynchronizationtherapypatients
AT osztheimeri prevalenceandimportanceoffrailtyincardiacresynchronizationtherapypatients
AT zimae prevalenceandimportanceoffrailtyincardiacresynchronizationtherapypatients
AT molnarl prevalenceandimportanceoffrailtyincardiacresynchronizationtherapypatients
AT gellerl prevalenceandimportanceoffrailtyincardiacresynchronizationtherapypatients
AT kosztina prevalenceandimportanceoffrailtyincardiacresynchronizationtherapypatients
AT merkelyb prevalenceandimportanceoffrailtyincardiacresynchronizationtherapypatients